pH-Sensitive mPEG-Hz-Cholesterol Conjugates as a Liposome Delivery System
Source abstract
Abstract
Hydrazone (Hz)-based pH-sensitive methoxy(polyethylene glycol)-cholesterol conjugates (mPEG-Hz-Chol), were synthesized and used to fabricate liposomes. The structures of the mPEG2000-Hz-Chol conjugate were confirmed by FT-IR and 1 H-NMR; they were stable at pH 7.4 but sensitive to mild acid conditions (pH 5.5). Plain liposomes were also prepared with S100PC/ Chol, and the pH-insensitive liposomes with S100PC/Chol/mPEG2000-Chol for comparison; all the liposomes were similar in diameter ∼200 nm. In vitro, the pH-sensitive liposomes released more of the model drug, paclitaxel (PTX), than the plain liposomes. The pH-sensitive liposomes were less toxic than the plain liposomes and exhibited higher cellular uptake of PTX compared with pH-insensitive liposomes by human breast cancer cells (MCF-7). The pHsensitive mPEG2000-Hz-Chol liposomes are now being investigated as a potential new liposome drug delivery system.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Pharmacy, China Pharmaceutical University Nanjing 210009, China, School of Pharmacy, Yantai University, Yantai 264005, China
Nanjing Hicin Pharmaceutical Co. Ltd, Nanjing 210009, China
College of Pharmacy, China Pharmaceutical University Nanjing 210009, China
College of Pharmacy, China Pharmaceutical University Nanjing 210009, China,
References (19)
Show source-provided references
1. 10.1016/j.colsurfb.2007.05.00610.1016/j.colsurfb.2007.05.006 ↗
2. 10.1016/0005-2736(91)90162-210.1016/0005-2736(91)90162-2 ↗
3. 10.1016/S0168-3659(03)00232-310.1016/S0168-3659(03)00232-3 ↗
4. 10.1080/0898210070152503510.1080/08982100701525035 ↗
5. 10.1016/S0378-5173(98)00188-410.1016/S0378-5173(98)00188-4 ↗
6. 10.1016/S0378-5173(01)00986-310.1016/S0378-5173(01)00986-3 ↗
7. Gelderblom, H. · J. Cancer · 2001 · 37 · 1590
8. 10.1016/j.ejpb.2004.06.00910.1016/j.ejpb.2004.06.009 ↗
9. 10.1016/j.colsurfb.2007.11.01910.1016/j.colsurfb.2007.11.019 ↗
10. 10.1177/088391150910378310.1177/0883911509103783 ↗
11. 10.1016/j.colsurfb.2006.11.03110.1016/j.colsurfb.2006.11.031 ↗
12. 10.1016/j.biomaterials.2007.11.02910.1016/j.biomaterials.2007.11.029 ↗
13. 10.1016/0304-3835(96)04380-710.1016/0304-3835(96)04380-7 ↗
14. 10.1177/088391150809749810.1177/0883911508097498 ↗
15. 10.1016/j.jconrel.2007.05.01110.1016/j.jconrel.2007.05.011 ↗
16. 10.1016/S0005-2736(01)00411-410.1016/S0005-2736(01)00411-4 ↗
17. 10.1016/j.ijpharm.2004.10.00910.1016/j.ijpharm.2004.10.009 ↗
18. 10.1177/088391150809524510.1177/0883911508095245 ↗
19. 10.1177/088391150934968710.1177/0883911509349687 ↗